Belpointe Asset Management LLC Ac Immune Sa Transaction History

Belpointe Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$1.72 - $3.12 $1,720 - $3,120	1,000 New	1,000 $2,000
Q4 2018 Mar 06, 2019	SELL	$7.35 - $11.7 $367,500 - $585,000	-50,000 Closed	0 $0
Q3 2018 Nov 23, 2018	BUY	$7.88 - $16.45 $394,000 - $822,500	50,000 New	50,000 $400,000
Q1 2018 Aug 06, 2018	SELL	$10.34 - $13.78 $524,755 - $699,335	-50,750 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$10.37 - $12.85 $3,629 - $4,497	-350 Reduced 0.68%	50,750 $650,000
Q3 2017 Nov 16, 2017	BUY	$7.06 - $11.2 $360,766 - $572,320	51,100	51,100 $571,000

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $224M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.